FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of Genetic Technologies

Genetic Technologies grants third license to Monsanto

09-Aug-2010 - Genetic Technologies Limited announced that it has granted a third license to Monsanto Company. Genetic Technologies had previously granted a non-exclusive license to the GTG non-coding patents to Monsanto in 2007 for all applications in plants and plant products. Soon after, GTG also granted ...

license agreements Monsanto patent infringement +1

Genetic Technologies appoints Lewis J. Stuart as General Manager of its New North American Molecular Diagnostics Business

23-Jun-2010 - Genetic Technologies Limited announced the appointment of Mr. Lewis Stuart as General Manager of its North American molecular diagnostics business. The new division is the result of the Company’s recent acquisition of US assets including BREVAGen™, a fully validated risk assessment test for ...

biotechnology breast cancer Bristol-Myers Squibb +7

All of GTG’s Core Non-Coding DNA Patent Claims Upheld in Full by US Patent and Trademark Office

10-May-2010 - Genetic Technologies Limited has received formal notification from the United States Patent and Trademarks Office (USPTO) that it has upheld, without amendment, all of the claims which formed the basis of the re-examination action (ASX announcement June 30th, 2009) of the Company’s core 5,612,179 ...

deoxyribonucleic acid non-coding DNA patents

Genetic Technologies Grants License to Genzyme for Human Genetic Testing Applications

12-Oct-2004 - Melbourne. Genetic Technologies Limited ("GTG") has granted a license to Genzyme Corporation for human testing applications as part of the first step in a new collaboration. Under the license agreement, Genzyme will pay GTG a signing fee and an annual fee for the life of certain non-coding ...

clinical trials Genzyme Japan +3